Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus

Autor: Potashman MH, Stokes M, Liu J, Lawrence R, Harris L

Publikováno v: Infection and Drug Resistance, Vol 2016, Iss Issue 1, Pp 19-33 (2016)

Michele H Potashman,1 Michael Stokes,2 Jieruo Liu,2 Robin Lawrence,1 Linda Harris1 1Global Health Outcomes, Merck & Co, Inc., Kenilworth, NJ, USA; 2Evidera, Lexington, MA, USA Purpose: Skin infections, particularly those caused by resistant pathogens

Externí odkaz: https://doaj.org/article/3dd107ba0fe7426894baa94d096a50dc

Determinants of health-related quality of life of patients with focal epilepsy: A systematic literature review.

Autor: Engelhart P; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA., Marcin C; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA., Lerner J; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA., Dill D; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA., L'Italien G; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA., Coric V; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA., Matsumoto J; UCLA School of Medicine, Los Angeles, California, USA., Potashman MH; Biohaven Pharmaceuticals, Inc, New Haven, Connecticut, USA.

Publikováno v: Epileptic disorders : international epilepsy journal with videotape [Epileptic Disord] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.

Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis.

Autor: L'Italien GJ; Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, 06510, USA., Oikonomou EK; Yale School of Medicine, New Haven, CT, USA., Khera R; Yale School of Medicine, New Haven, CT, USA., Potashman MH; Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, 06510, USA. michele.potashman@biohavenpharma.com., Beiner MW; Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, 06510, USA., Maclaine GDH; Biohaven Bioscience Ireland Ltd, Dublin, Ireland., Schmahmann JD; Ataxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Perlman S; Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA., Coric V; Biohaven Pharmaceuticals, Inc., 215 Church Street, New Haven, CT, 06510, USA.

Publikováno v: Neurology and therapy [Neurol Ther] 2024 Aug; Vol. 13 (4), pp. 1287-1301. Date of Electronic Publication: 2024 May 30.

What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review.

Autor: Tochel C; Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK., Smith M; Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK., Baldwin H; Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.; University of Oxford, Oxford, UK., Gustavsson A; Quantify Research, Stockholm, Sweden.; Department of Neurobiology, Care Sciences & Society, Karolinska Institute, Stockholm, Sweden.; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Ly A; Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK., Bexelius C; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Nelson M; Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK., Bintener C; Alzheimer Europe, Luxembourg City, Luxembourg., Fantoni E; GE Healthcare, Life Sciences, Amersham, UK., Garre-Olmo J; Girona Biomedical Research Institute (IdibGI), Girona, Catalonia, Spain., Janssen O; Department of Psychiatry & Neuropsychology, School for Mental Health & Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands., Jindra C; Department of Psychiatry, University of Oxford, Oxford, UK., Jørgensen IF; Novo Nordisk Foundation Center for Protein Research, Faculty of Health & Medical Sciences, University of Copenhagen, Copenhagen, Denmark., McKeown A; University of Oxford, Oxford, UK., Öztürk B; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark., Ponjoan A; Girona Biomedical Research Institute (IdibGI), Girona, Catalonia, Spain.; Vascular Health Research Group (ISV-Girona), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Catalonia, Spain., Potashman MH; Biogen, Cambridge, MA, USA., Reed C; Eli Lilly and Company Limited, Windlesham, UK., Roncancio-Diaz E; GE Healthcare, Life Sciences, Amersham, UK., Vos S; Department of Psychiatry & Neuropsychology, School for Mental Health & Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands., Sudlow C; Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Publikováno v: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2019 Mar 07; Vol. 11, pp. 231-247. Date of Electronic Publication: 2019 Mar 07 (Print Publication: 2019).

Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol.

Autor: Landeiro F; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Walsh K; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Ghinai I; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Mughal S; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Nye E; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Wace H; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Roberts N; Bodleian Health Care Libraries, University of Oxford, Oxford, UK., Lecomte P; Health Economic Modelling and Methodology, Novartis Pharma AG, Basel, Switzerland., Wittenberg R; Personal Social Services Research Unit, London School of Economics and Political Science, London, UK., Wolstenholme J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Handels R; Alzheimer Centre Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands.; Division of Neurogeriatrics, Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden., Roncancio-Diaz E; Life Sciences, GE Healthcare, Amersham, UK., Potashman MH; Value and Access, Biogen, Cambridge, Massachusetts, USA., Tockhorn-Heidenreich A; GPORWE International, Eli Lilly and Company, Windlesham, UK., Gray AM; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Publikováno v: BMJ open [BMJ Open] 2018 Mar 30; Vol. 8 (3), pp. e019082. Date of Electronic Publication: 2018 Mar 30.